Technical Analysis for JSPR - Jasper Therapeutics, Inc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bearish Signal Line Cross | Bearish | 1.84% | |
Wide Bands | Range Expansion | 1.84% | |
20 DMA Resistance | Bearish | -5.23% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.23% | |
Inside Day | Range Contraction | -5.23% | |
Wide Bands | Range Expansion | -5.23% | |
50 DMA Resistance | Bearish | -3.83% | |
Bearish Engulfing | Bearish | -3.83% | |
Fell Below 20 DMA | Bearish | -3.83% | |
Expansion Pivot Sell Setup | Bearish Swing Setup | -3.83% |
Alert | Time |
---|---|
10 DMA Resistance | about 2 hours ago |
Up 5% | about 2 hours ago |
Up 3% | about 2 hours ago |
Fell Below Previous Day's Low | about 2 hours ago |
Up 2% | about 2 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. The company develops JSP191, a humanized monoclonal antibody for clearing hematopoietic stem cells from bone marrow in patients undergoing a hematopoietic cell transplantation. It also develops Jasper eHSC Platform to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cell Gene Therapy Transplantation Bone Marrow Hematopoietic Stem Cell
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Stem Cell Gene Therapy Transplantation Bone Marrow Hematopoietic Stem Cell
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 31.01 |
52 Week Low | 4.0 |
Average Volume | 95,075 |
200-Day Moving Average | 13.79 |
50-Day Moving Average | 25.33 |
20-Day Moving Average | 23.44 |
10-Day Moving Average | 22.63 |
Average True Range | 2.01 |
RSI (14) | 39.76 |
ADX | 21.37 |
+DI | 19.18 |
-DI | 28.46 |
Chandelier Exit (Long, 3 ATRs) | 24.22 |
Chandelier Exit (Short, 3 ATRs) | 26.19 |
Upper Bollinger Bands | 27.73 |
Lower Bollinger Band | 19.15 |
Percent B (%b) | 0.24 |
BandWidth | 36.63 |
MACD Line | -0.80 |
MACD Signal Line | -0.71 |
MACD Histogram | -0.0913 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 24.40 | ||||
Resistance 3 (R3) | 24.74 | 24.00 | 23.87 | ||
Resistance 2 (R2) | 24.00 | 23.19 | 23.84 | 23.69 | |
Resistance 1 (R1) | 22.60 | 22.68 | 22.23 | 22.26 | 23.51 |
Pivot Point | 21.86 | 21.86 | 21.68 | 21.70 | 21.86 |
Support 1 (S1) | 20.46 | 21.05 | 20.09 | 20.12 | 18.87 |
Support 2 (S2) | 19.72 | 20.54 | 19.56 | 18.69 | |
Support 3 (S3) | 18.32 | 19.72 | 18.52 | ||
Support 4 (S4) | 17.98 |